PM360

JUNE 16, 2023

In 2007, Alexion set a new pricing milestone of $500,000 annually for Soliris , a treatment for an ultra-rare blood disorder. In many cases, the biotech companies leading the commercialization in the U.S. As Payment Structures Change, Patient Access Must Evolve Rare diseases take the U.S. In the U.S.,

Marketing 98

Marketing Management Insurance Specialization 98

Clarivate

APRIL 24, 2023

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients. Key acquisitions by U.S. healthcare organizations Company Founded Type No.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

European Pharmaceutical Review

SEPTEMBER 14, 2023

In 2001 and 2007, through 2009, the economy was hit hard. Therefore, it is best to collaborate with leading experts and scientists you can trust with your molecule. About the author Brandon Fincher is President of Early Stage Development & Testing at Cambrex, a leading global CDMO.

Manufacturing 98

Manufacturing Management Engineering Pharmaceutical 98

European Pharmaceutical Review

JUNE 28, 2022

According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide accounting for 32 percent of global deaths in 2019 (approximately 17.9 percent of patients taking empagliflozin for around 14 months were hospitalised for heart failure or died of cardiovascular causes, compared with 24.7 for placebo.

Food and Drug Administration 98

Food and Drug Administration Patients Medicine FDA 98

European Pharmaceutical Review

DECEMBER 20, 2023

The proposed changes to EU pharmaceutical legislation broadly aim to: Support innovation and boost attractiveness of EU market Ensure timely and equitable access to medicines for patients across the EU Address other ongoing issues, including antimicrobial resistance and environmental impact of medicines.

Biopharma 98

Biopharma Pharmaceutical Medicine Manufacturing 98

pharmaphorum

JULY 15, 2022

The case hinges around the concept of “ skinny labelling ” which was introduced to stop drugmakers extending the exclusivity period for their branded medicines – through a stream of new indications or patient populations – that can be protected with so-called “use” patents. The substance patent expired in 2007.

Prescription 52

Prescription Marketing Doctors Government 52

pharmaphorum

NOVEMBER 30, 2022

Founded in 2007 by Peter Gassner, a luminary of Silicon Valley with a net worth of circa $5.25 With an eye on launch and commercialisation, the key is gaining access to patients for studies. When we think about the problems, Shawah said, it’s about getting the right medicine to the right patient.

Pharma 98

Pharma Consulting Marketing Sales 98

CloserIQ

OCTOBER 10, 2018

Founded 2007. Founded 2007. They’ve worked with leading clients such as Twitter and Mercedes Benz. Kyruus is revolutionizing healthcare with its data-driven system that makes it easier for healthcare system to match patients to appropriate providers. Founded 2007. Founded 2007. 3Play Media. See open roles.

Sales 76

Sales Management Marketing Education 76

European Pharmaceutical Review

JULY 20, 2023

In June 2023, an array of leading voices in AAV development for cell and gene therapies articulated the current challenges and their optimism for the rapidly advancing sector at the Cell and Gene Therapy Summit event in London. She also touched on production costs being irrecoverable—there is a high cost per patient.

Consulting 74

Consulting Manufacturing Side effects Safety 74

PM360

NOVEMBER 21, 2024

Prior to that, he was named Lead Independent Director in 2019 after serving as a director of the company since 2013. Prior to becoming President of Global Human Health, he served as President of Merck’s global pharmaceutical business from 2007 to 2010. Keytruda has transformed so many patients’ lives around the world.

Ethics 59

Ethics Food and Drug Administration Marketing Healthcare 59

Clarivate

MAY 8, 2023

s BioIndustry Association, recalling the establishment of Polar Capital Partners on the eve of the financial crisis in 2007. You have to be patiently impatient,” he said. KuDOS’ lead asset, cancer drug olaparib (AKA LYNPARZA®), went on to generate sales of $2.9 It’s a lesson in doing things too early,” said Martin.

Biopharma 52

Biopharma Sales Networking Pharma 52

Evolve Your Success

JANUARY 10, 2023

These four players operate and navigate the space of orthopedics in the robust portfolios that exist to keep patients moving. There’s a weight that comes with sales consultants in my organization and the jobs we like to do to support our surgeons and patients. Once again, it’s not anything elective. It’s not planned.

Sales 130

Sales Medical sales Consulting Medical 130

Healthcare Success

MAY 22, 2024

Remember, even a patient’s email address could be considered PHI if linked to a health condition or treatment. Most healthcare marketers are unaware that seemingly innocuous patient email marketing campaigns are yet another area where you could inadvertently run afoul with HIPAA regulations, or, even worse, suffer a breach.

Marketing 68

Marketing Healthcare Healthcare Patients 68

PM360

NOVEMBER 12, 2024

One in three people is expected to develop a neurological condition in their lifetime, and neurological diseases are the leading cause of disability. Through the years, the one constant has been how leaders can collaborate and inspire great people working in teams to develop medicines that truly make a difference for patients.

Food and Drug Administration 52

Food and Drug Administration Healthcare Provider Healthcare Healthcare 52

European Pharmaceutical Review

MARCH 1, 2023

Since these particles are usually very small and are located inside the cake, they cannot be detected during conventional optical inspection, thus posing great potential risk to patients. Weinheim: Wiley 2007. ” The aforementioned examples illustrate that CT could enable full automated characterisation of vials in the future.

Distribution 98

Distribution Pharmaceutical Electronics Food 98

Pharmaceutical Technology

AUGUST 26, 2008

.” By the early 2000s AstraZeneca had already realised the critical importance of biotechnology, making a number of strategic investments in biotech companies, Abgenix in 2003, Cambridge Antibody Technology in 2006 and culminating in its acquisition of US biotech firm, Medimmune in April 2007 for £15bn.

Pharmaceutical 40

Pharmaceutical Manufacturing Biopharma Medicine 40

Healthcare Success

APRIL 1, 2025

Prioritize the patient conversion process. Why This Episode Matters Its packed with insights on refining your digital marketing approach to ensure every ad dollar spent leads to real patient conversions. Brian Massey (Conversion Sciences) Yeah so in 2007 I founded conversion sciences. What else could you do?

Healthcare 65

Healthcare Healthcare Consulting Marketing 65